Modifies provisions relating to advanced practice registered nurses
Impact
The impact of HB3040 on state laws is notably seen in its amendment of existing regulations concerning the prescriptive authority of APRNs. By repealing previous sections and enacting new provisions, the bill aligns APRN practices with modern healthcare needs, particularly in the management of controlled substances. This shift could improve patient access to necessary medications and healthcare services. Moreover, it facilitates nurse practitioners' capabilities in diverse settings, including rural and underserved areas where physician availability is limited.
Summary
House Bill 3040 modifies the provisions surrounding advanced practice registered nurses (APRNs) in Missouri. The bill introduces new sections that allow APRNs who hold a certificate of controlled substance prescriptive authority to prescribe controlled substances under a collaborative practice arrangement with a physician. This change is significant as it expands the role of APRNs in the healthcare system, enabling them to offer more comprehensive care, especially in areas where there is a shortage of healthcare providers. It aims to enhance healthcare delivery by giving nurses more autonomy in prescribing medications.
Contention
During discussions surrounding the bill, notable points of contention emerged regarding the delegation of authority within collaborative practice arrangements. Concerns were raised about the safety and oversight of APRN prescribing practices, especially related to controlled substances. Critics feared that without adequate supervision and guidelines, this could lead to potential over-prescription or misuse of medications. Advocates, however, argued that empowering APRNs to prescribe independently within a collaborative framework would ultimately improve patient care and efficiency in healthcare delivery, given their extensive training and expertise.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25
Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25
Criminal procedure: sentencing guidelines; sentencing guidelines for manufacturing, creating, delivering, or possessing with intent certain schedule 1 and 2 controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 460'25
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver heroin or fentanyl; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 0430'25